<\/p>\n
This update provides information such as a study summary, eligibility criteria, and a list of participating center locations. If you are interested in participating in this study or you have more questions, please contact the center nearest to you.<\/p>\n
A total of 1,300 subjects with CSS, GCA, MPA, PAN, TAK, and WG will be enrolled in this study. Study subjects will only be seen once for this research study.<\/p>\n
For this visit, you will be asked to:<\/p>\n
The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of these studies will provide researchers in vasculitis with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researchers investigating vasculitis and other autoimmune, inflammatory, and vascular diseases.<\/p>\n
Be an individual with a confirmed diagnosis of one of the following:<\/p>\n
Please do not respond to this e-mail. In order to participate in a study, you must personally<\/em> contact any of the participating institutions listed below by phone or e-mail.<\/p>\n Please contact the participating institution that is closest to your location.<\/p>\n [column col=”1\/2″]Boston University School of Medicine (VCRC)<\/strong> [column col=”1\/2″]Cleveland Clinic Foundation (VCRC)<\/strong> [column col=”1\/2″]Hospital for Special Surgery (VCRC)<\/strong> [column col=”1\/2″]<\/strong>Mayo Clinic (VCRC)<\/strong> [column col=”1\/2″]Mount Sinai Hospital, Toronto (VCRC)<\/strong> [column col=”1\/2″]St. Joseph’s Healthcare Hamilton (VCRC)<\/strong> [column col=”1\/2″]University of California at San Francisco (VCRC)<\/strong> [column col=”1\/2″]University of Pennsylvania (VCRC)<\/strong> [column col=”1\/2″]University of Pittsburgh (VCRC)<\/strong> [column col=”1\/2″]University of Utah (VCRC)<\/strong> About this study This update provides information such as a […]<\/p>\n","protected":false},"author":2059,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-95","post","type-post","status-publish","format-standard","hentry","category-research"],"_links":{"self":[{"href":"https:\/\/vasculitis.ca\/index.php?rest_route=\/wp\/v2\/posts\/95","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vasculitis.ca\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vasculitis.ca\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vasculitis.ca\/index.php?rest_route=\/wp\/v2\/users\/2059"}],"replies":[{"embeddable":true,"href":"https:\/\/vasculitis.ca\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=95"}],"version-history":[{"count":0,"href":"https:\/\/vasculitis.ca\/index.php?rest_route=\/wp\/v2\/posts\/95\/revisions"}],"wp:attachment":[{"href":"https:\/\/vasculitis.ca\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=95"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vasculitis.ca\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=95"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vasculitis.ca\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=95"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nBoston, Massachusetts
\nPrincipal Investigator: Paul Monach
\nContact Person: Daniel Finkel
\nOffice: 617-414-2509
\nEmail: dfinkel@bu.edu[\/column]
\n[column col=”1\/2″]Cedars-Sinai Medical Center (VCRC)<\/strong>
\nLos Angeles, California
\nPrincipal Investigator: Michael Weisman, M.D.
\nContact Person: Denise Salinas
\nOffice: 310-360-9197
\nEmail: Denise.Salinas@cshs.org<\/a>[\/column]<\/p>\n
\nCleveland, Ohio
\nPrincipal Investigator: Carol Langford, MD, MHS
\nContact Person: Katie Gartner
\nOffice: 216-445-1397
\nEmail: gartnek@ccf.org<\/a>[\/column]<\/p>\n
\nNew York, New York
\nPrincipal Investigator: Robert Spiera, MD
\nContact Person: Uzunma Udeh
\nOffice: 212-774-2123
\nEmail: udehu@hss.edu<\/a>[\/column]<\/p>\n
\nRochester, Minnesota
\nPrincipal Investigator: Ulrich Specks, MD
\nContact Person: Sara Biorn
\nOffice: 507-284-4862
\nEmail: biorn.sara@mayo.edu<\/a>[\/column]<\/p>\n
\nToronto, Ontario Canada
\nPrincipal Investigator: Simon Carette, MD
\nContact Person: Julia Farquharson
\nOffice: 416-586-8616
\nEmail: jfarquharson@mtsinai.on.ca<\/a>[\/column]<\/p>\n
\nHamilton, Ontario Canada
\nPrincipal Investigator: Nader Khalidi, MD
\nContact Person: Sandra Messier, RCT
\nOffice: 905-522-1155 x 35873
\nEmail: smessier@stjoes.ca<\/a>[\/column]<\/p>\n
\nSan Francisco, California
\nPrincipal Investigator: Sharon Chung, MD
\nContact Person: Ruby Harrison
\nOffice: 415-514-3502
\nEmail: ruby.harrison@ucsf.edu<\/a>[\/column]<\/p>\n
\nPhiladelphia, Pennsylvania
\nPrincipal Investigator: Peter Merkel, MD, MPH
\nContact Person: Alexandra Giardino
\nOffice: 215-614-4407
\nEmail: alexandra.giardino@uphs.upenn.edu<\/a>[\/column]<\/p>\n
\nPittsburgh, Pennsylvania
\nPrincipal Investigator: Larry Moreland, MD
\nContact Person: Dawn McBride, RN, BA
\nOffice: 412-586-3545
\nEmail: dlmc@pitt.edu<\/a>[\/column]<\/p>\n
\nSalt Lake City, Utah
\nPrincipal Investigator: Curry Koening, MD, MS
\nContact Person: Julieanne Nielsen, BS
\nOffice: 801-585-0798
\nEmail: Julieanne.Nielsen@hsc.utah.edu<\/a>[\/column]<\/p>\n","protected":false},"excerpt":{"rendered":"